Benchmarking omics-based prediction of asthma development in children

Abstract Background Asthma is a heterogeneous disease with high morbidity. Advancement in high-throughput multi-omics approaches has enabled the collection of molecular assessments at different layers, providing a complementary perspective of complex diseases. Numerous computational methods have bee...

Full description

Bibliographic Details
Main Authors: Xu-Wen Wang, Tong Wang, Darius P. Schaub, Can Chen, Zheng Sun, Shanlin Ke, Julian Hecker, Anna Maaser-Hecker, Oana A. Zeleznik, Roman Zeleznik, Augusto A. Litonjua, Dawn L. DeMeo, Jessica Lasky-Su, Edwin K. Silverman, Yang-Yu Liu, Scott T. Weiss
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-023-02368-8
_version_ 1827983066369359872
author Xu-Wen Wang
Tong Wang
Darius P. Schaub
Can Chen
Zheng Sun
Shanlin Ke
Julian Hecker
Anna Maaser-Hecker
Oana A. Zeleznik
Roman Zeleznik
Augusto A. Litonjua
Dawn L. DeMeo
Jessica Lasky-Su
Edwin K. Silverman
Yang-Yu Liu
Scott T. Weiss
author_facet Xu-Wen Wang
Tong Wang
Darius P. Schaub
Can Chen
Zheng Sun
Shanlin Ke
Julian Hecker
Anna Maaser-Hecker
Oana A. Zeleznik
Roman Zeleznik
Augusto A. Litonjua
Dawn L. DeMeo
Jessica Lasky-Su
Edwin K. Silverman
Yang-Yu Liu
Scott T. Weiss
author_sort Xu-Wen Wang
collection DOAJ
description Abstract Background Asthma is a heterogeneous disease with high morbidity. Advancement in high-throughput multi-omics approaches has enabled the collection of molecular assessments at different layers, providing a complementary perspective of complex diseases. Numerous computational methods have been developed for the omics-based patient classification or disease outcome prediction. Yet, a systematic benchmarking of those methods using various combinations of omics data for the prediction of asthma development is still lacking. Objective We aimed to investigate the computational methods in disease status prediction using multi-omics data. Method We systematically benchmarked 18 computational methods using all the 63 combinations of six omics data (GWAS, miRNA, mRNA, microbiome, metabolome, DNA methylation) collected in The Vitamin D Antenatal Asthma Reduction Trial (VDAART) cohort. We evaluated each method using standard performance metrics for each of the 63 omics combinations. Results Our results indicate that overall Logistic Regression, Multi-Layer Perceptron, and MOGONET display superior performance, and the combination of transcriptional, genomic and microbiome data achieves the best prediction. Moreover, we find that including the clinical data can further improve the prediction performance for some but not all the omics combinations. Conclusions Specific omics combinations can reach the optimal prediction of asthma development in children. And certain computational methods showed superior performance than other methods.
first_indexed 2024-04-09T22:41:48Z
format Article
id doaj.art-992fccd1d96f4636a1f4594427e2d343
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-04-09T22:41:48Z
publishDate 2023-02-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-992fccd1d96f4636a1f4594427e2d3432023-03-22T12:08:09ZengBMCRespiratory Research1465-993X2023-02-0124111110.1186/s12931-023-02368-8Benchmarking omics-based prediction of asthma development in childrenXu-Wen Wang0Tong Wang1Darius P. Schaub2Can Chen3Zheng Sun4Shanlin Ke5Julian Hecker6Anna Maaser-Hecker7Oana A. Zeleznik8Roman Zeleznik9Augusto A. Litonjua10Dawn L. DeMeo11Jessica Lasky-Su12Edwin K. Silverman13Yang-Yu Liu14Scott T. Weiss15Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Mathematics, University of HamburgChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolGenetics and Aging Research Unit, Department of Neurology, McCance Center for Brain Health, Mass General Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Radiation Oncology, Brigham and Women’s HospitalDivision of Pediatric Pulmonology, Golisano Children’s HospitalChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolChanning Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolAbstract Background Asthma is a heterogeneous disease with high morbidity. Advancement in high-throughput multi-omics approaches has enabled the collection of molecular assessments at different layers, providing a complementary perspective of complex diseases. Numerous computational methods have been developed for the omics-based patient classification or disease outcome prediction. Yet, a systematic benchmarking of those methods using various combinations of omics data for the prediction of asthma development is still lacking. Objective We aimed to investigate the computational methods in disease status prediction using multi-omics data. Method We systematically benchmarked 18 computational methods using all the 63 combinations of six omics data (GWAS, miRNA, mRNA, microbiome, metabolome, DNA methylation) collected in The Vitamin D Antenatal Asthma Reduction Trial (VDAART) cohort. We evaluated each method using standard performance metrics for each of the 63 omics combinations. Results Our results indicate that overall Logistic Regression, Multi-Layer Perceptron, and MOGONET display superior performance, and the combination of transcriptional, genomic and microbiome data achieves the best prediction. Moreover, we find that including the clinical data can further improve the prediction performance for some but not all the omics combinations. Conclusions Specific omics combinations can reach the optimal prediction of asthma development in children. And certain computational methods showed superior performance than other methods.https://doi.org/10.1186/s12931-023-02368-8AsthmaDisease statusPredictionMulti-omics
spellingShingle Xu-Wen Wang
Tong Wang
Darius P. Schaub
Can Chen
Zheng Sun
Shanlin Ke
Julian Hecker
Anna Maaser-Hecker
Oana A. Zeleznik
Roman Zeleznik
Augusto A. Litonjua
Dawn L. DeMeo
Jessica Lasky-Su
Edwin K. Silverman
Yang-Yu Liu
Scott T. Weiss
Benchmarking omics-based prediction of asthma development in children
Respiratory Research
Asthma
Disease status
Prediction
Multi-omics
title Benchmarking omics-based prediction of asthma development in children
title_full Benchmarking omics-based prediction of asthma development in children
title_fullStr Benchmarking omics-based prediction of asthma development in children
title_full_unstemmed Benchmarking omics-based prediction of asthma development in children
title_short Benchmarking omics-based prediction of asthma development in children
title_sort benchmarking omics based prediction of asthma development in children
topic Asthma
Disease status
Prediction
Multi-omics
url https://doi.org/10.1186/s12931-023-02368-8
work_keys_str_mv AT xuwenwang benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT tongwang benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT dariuspschaub benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT canchen benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT zhengsun benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT shanlinke benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT julianhecker benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT annamaaserhecker benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT oanaazeleznik benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT romanzeleznik benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT augustoalitonjua benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT dawnldemeo benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT jessicalaskysu benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT edwinksilverman benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT yangyuliu benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren
AT scotttweiss benchmarkingomicsbasedpredictionofasthmadevelopmentinchildren